You just read:

Theravance Biopharma Highlights Initiation of Phase 3 Study of the Closed Triple in Patients with Asthma by GlaxoSmithKline and Innoviva

News provided by

Theravance Biopharma, Inc.

19 Dec, 2016, 17:45 ET